Migratory properties of neoplastic cells have long been suggested to play a central role in invasion and metastasis. We have previously demonstrated that cell adhesion, rearrangement of extracellular matrix, assembly of cytoskeleton networks, cell geometry and locomotion are all closely interrelated properties affecting tumor cell dissemination. The nature of tumor cell surface molecules that are involved in mediating such processes is unknown. 'Motility' and 'chemotactic-factors' which regulate cell movement and positioning have recently been discovered although their complimentary receptors remain to be identified. In response to cell geometry modulation, B16-F1 melanoma cells express augmented glycosylation of a 78,000 KDa (gp78) cell surface glycoprotein which is correlated with increased metastatic ability in vivo and motility in vitro. Affinity purified gp78 binds a purified 55,000 KDa B16-F1 autocrine motility factor (AMF), and inhibits migratory stimulation by AMF. Cell motility stimulation by AMF is associated with gp78 phosphorylation. We have cloned the human homologue of the murine AMF receptor and found it to share significant sequence homology with the suppressor/oncogene p53 protein.
The aim of this project is to determine directly the role of AMF receptor in vitro (motility) and in vivo (hematogenous spread). In particular, we intend to: 1) identify the presence of gp78, its cell surface expression density and distribution in relation to the motility and the metastatic phenotypes of various tumor cell systems. 2) study the signal transduction pathway of motility stimulation. 3) clone AMF from mouse and human cDNA libraries. 4) identify and clone the murine gene(s) coding for gp78. 5) chromosomally map the human gp78 and cloned its wild-type (normal) homologue. 6) transfect specific gp78 coding sequences into tumor cells that express high and low metastatic ability and compare the expression of the newly synthesized AMF receptor with the malignant cell phenotype in relation to motility, growth and metastasis. It is expected that these studies will allow the characterization and establishment of the role of cell surface receptor for autocrine motility factor in cell kinesis and its relevance to invasion and metastatic spread.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA051714-02
Application #
3196353
Study Section
Pathology B Study Section (PTHB)
Project Start
1991-08-01
Project End
1994-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Barbara Ann Karmanos Cancer Institute
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48201
Kho, Dhong Hyo; Zhang, Tianpeng; Balan, Vitaly et al. (2014) Autocrine motility factor modulates EGF-mediated invasion signaling. Cancer Res 74:2229-37
Wang, Ying; Ha, Seung-Wook; Zhang, Tianpeng et al. (2014) Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases. Oncotarget 5:2044-51
Kho, Dhong Hyo; Nangia-Makker, Pratima; Balan, Vitaly et al. (2013) Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells. Cancer Res 73:1411-9
Ahmad, Aamir; Ali, Shadan; Ahmed, Alia et al. (2013) 3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells. PLoS One 8:e54657
Yanagawa, Takashi; Shinozaki, Tetsuya; Watanabe, Hideomi et al. (2012) Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas. Exp Cell Res 318:800-8
Ahmad, Aamir; Aboukameel, Amro; Kong, Dejuan et al. (2011) Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res 71:3400-9
Niinaka, Yasufumi; Harada, Kiyoshi; Fujimuro, Masahiro et al. (2010) Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res 70:9483-93
Araki, Kenichiro; Shimura, Tatsuo; Yajima, Toshiki et al. (2009) Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8. J Biol Chem 284:32305-11
Funasaka, Tatsuyoshi; Hogan, Victor; Raz, Avraham (2009) Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res 69:5349-56
Funasaka, Tatsuyoshi; Hu, Huankai; Hogan, Victor et al. (2007) Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence. J Biol Chem 282:36362-9

Showing the most recent 10 out of 59 publications